An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma
Clinical trial NCT02211014 · COMPLETED
Trial details
- NCT number
- NCT02211014
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2019-04-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.